Who are Razadyne's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Bloxiverz, Camptosar, Camptosar, Zantac, Flaxedil, Lorfan.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/galantamine.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-13 · How we verify

Razadyne — Competitive Intelligence Brief

Razadyne (GALANTAMINE) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Cholinesterase Inhibitor. Area: Neuroscience.

marketed Cholinesterase Inhibitor Acetylcholinesterase Neuroscience Small molecule Live · refreshed every 30 min

Target snapshot

Razadyne (GALANTAMINE) — Johnson & Johnson. Razadyne works by blocking the enzyme that breaks down acetylcholine, allowing more of this neurotransmitter to be available in the brain.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Razadyne TARGET	GALANTAMINE	Johnson & Johnson	marketed	Cholinesterase Inhibitor	Acetylcholinesterase	2001-01-01
Bloxiverz	NEOSTIGMINE	Fresenius Kabi	marketed	Cholinesterase Inhibitor	Acetylcholinesterase	2013-01-01
Camptosar	Irinotecan Hydrochloride	Pfizer	marketed	Topoisomerase Inhibitor	Acetylcholinesterase	1996-01-01
Camptosar	onivyde	Pfizer	marketed	Topoisomerase Inhibitor	Acetylcholinesterase	1996-01-01
Zantac	ranitidine	GSK (originally Glaxo)	marketed	H2 receptor antagonist	Multidrug and toxin extrusion protein 1, Acetylcholinesterase, Histamine H2 receptor	1983-06-01
Flaxedil	GALLAMINE	Davis And Geck	marketed	gallamine	Acetylcholine receptor subunit alpha, Acetylcholinesterase, Muscarinic acetylcholine receptor M1	1982-01-01
Lorfan	LEVALLORPHAN	Roche	marketed	levallorphan	Mu-type opioid receptor, Acetylcholinesterase, Mu-type opioid receptor	1982-01-01

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

2027-01-06 — Camptosar · 8329213 · US
2027-01-06 — Camptosar · 8329213 · Compound · US
2028-08-29 — Camptosar · 8147867 · Compound · US
2028-08-29 — Camptosar · 8147867 · US
2033-06-12 — Camptosar · 9364473 · US
2033-06-12 — Camptosar · 9452162 · US
2033-06-12 — Camptosar · 9492442 · US
2033-06-12 — Camptosar · 9717724 · US
2033-06-12 — Camptosar · 9717724 · Method of Use · US
2033-06-12 — Camptosar · 9364473 · Method of Use · US
2033-06-12 — Camptosar · 12364691 · Method of Use · US
2033-06-12 — Camptosar · 11369597 · Method of Use · US
2033-06-12 — Camptosar · 9339497 · Method of Use · US
2033-06-12 — Camptosar · 9452162 · Method of Use · US
2033-06-12 — Camptosar · 9492442 · Method of Use · US
2033-06-12 — Camptosar · 10980795 · US
2033-06-12 — Camptosar · 11369597 · US
2033-06-12 — Camptosar · 9339497 · US
2033-06-12 — Camptosar · 10980795 · Method of Use · US
2036-08-19 — Camptosar · 11344552 · Method of Use · US
2036-10-15 — Camptosar · 10456360 · US
2036-10-15 — Camptosar · 10993914 · US
2036-10-15 — Camptosar · 12059497 · Formulation · US
2036-10-15 — Camptosar · 10456360 · Formulation · US
2036-10-15 — Camptosar · 10993914 · Formulation · US

Sponsor landscape (Cholinesterase Inhibitor class)

· 1 drug in this class
Eisai · 1 drug in this class
Fera Pharms Llc · 1 drug in this class
Fresenius Kabi · 1 drug in this class
Johnson & Johnson · 1 drug in this class
Sanofi · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Razadyne — Competitive Intelligence Brief. https://druglandscape.com/ci/galantamine. Accessed 2026-05-13.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab